Advertisement

Human Albumin on the Intensive Care Unit: Can We Live Without It?

  • J. Boldt
Conference paper
Part of the Yearbook of Intensive Care and Emergency Medicine book series (YEARBOOK, volume 2000)

Abstract

Hypovolemia is extremely common among intensive care patients. Fluid deficits can occur in the absence of obvious fluid loss (e.g., hemorrhage) most likely secondary to generalized alterations of the endothelial barrier resulting in diffuse capillary leakage. Principles of volume replacement therapy have been comprehensively reviewed elsewhere [1].

Keywords

Intensive Care Unit Patient Human Albumin Intensive Care Patient Volume Replacement Colloid Osmotic Pressure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Haupt MT (1993) Therapy: Effects of fluid resuscitation. In: Edwards JD, Shoemaker WC, Vincent JL (eds) Oxygen transport principles and practice. Balliere Tindall, London, pp 175–192Google Scholar
  2. 2.
    Hebert P, Wells G, Blajchman A, et al (1999) A multicenter randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 340: 409–417PubMedCrossRefGoogle Scholar
  3. 3.
    Conrad S, Dietch K, Hebert C (1990) Effects of red cell transfusion on oxygen consumption following fluid resuscitation in septic shock. Circ Shock 31: 419–429PubMedGoogle Scholar
  4. 4.
    Agrawal N, Murphy JG, Cayten CG, Stahl WM (1993) Blood transfusion increases the risk of infection after trauma. Arch Surg 128: 171–177CrossRefGoogle Scholar
  5. 6.
    Cochrane Injuries Group Albumin Reviewers (1998) Human albumin administration in critically ill patients: systematic review of randomised controlled trials. Br Med J 317: 235–239CrossRefGoogle Scholar
  6. 7.
    Schierhout G, Roberts I (1998) Fluid resuscitation with colloids or crystalloids in critically ill patients: a systematic review of randomised trials. Br Med J 316: 961–964CrossRefGoogle Scholar
  7. 8.
    Schuller D, Schuster DP (1997) The rationale for fluid restriction during treatment for ARDS. Semin Resp Crit Care Med 18: 33–38CrossRefGoogle Scholar
  8. 9.
    Suffredini AF (1994) Currrent prospects for the treatment of clinical sepsis. Crit Care Med 22: S12 - S18PubMedCrossRefGoogle Scholar
  9. 10.
    Ley K (1992) Leukocyte adhesion to vascular endothelium. J Reconstr Microsurg 8: 495–503PubMedCrossRefGoogle Scholar
  10. 11.
    Ellman H (1982) Capillary permeability in septic patients. Crit Care Med 10: 159–162CrossRefGoogle Scholar
  11. 12.
    Groeneveld AB, Teule GJ, Bronsveld, van den Bos C, Thijs LG (1987) Increased systemic micro-vascular albumin flux in septic shock. Intensive Care Med 13: 140–142PubMedCrossRefGoogle Scholar
  12. 13.
    Yamazaki M, Asakura H, Sato T, et al (1992) Changes in plasma levels of thrombomodulin during haemodialysis. Blood Coagul Fibrinolysis 3: 113–117PubMedCrossRefGoogle Scholar
  13. 14.
    Chaudry IH, Ayala A (1993) Immune consequences of hypovolemic shock and resuscitation. Curr Opin Anesth 6: 385–392CrossRefGoogle Scholar
  14. 15.
    Intaglietta M (1990) Objectives for the treatment of the microcirculation in ischema, shock, and reperfusion. In: Vincent JL (ed) Update in Intensive Care and Emergency Medicine. Springer, Heidelberg, pp 293–298Google Scholar
  15. 16.
    Boldt J, Lenz M, Kumle B, Papsdorf M (1998) Volume replacement strategies on intensive care units: results from a postal survey. Intensive Care Med 24: 147–151PubMedCrossRefGoogle Scholar
  16. 17.
    Kapila A, Waldman CS, Uncles DR, Addy EV (1995) Survey of colloid usage in British intensive care units. Clin Intensive Care 6: A201 (Abst)Google Scholar
  17. 18.
    Hauser CJ, Shoemaker WC, Turpin I (1980) Oxygen transport responses to colloids and crystalloids in critically ill surgical patients. Surg Gynecol Obstet 150: 811–816PubMedGoogle Scholar
  18. 19.
    Vincent JL (1991) Plugging the leaks? New insights into synthetic colloids. Crit Care Med 19: 316–318PubMedCrossRefGoogle Scholar
  19. 20.
    Finch JS, Reid C, Bandy K, Kickle D (1983) Compared effects of selected colloids on extravascular lung water in dogs after oleic acid induced lung injury and severe hemorrhage. Crit Care Med 11: 267–270PubMedCrossRefGoogle Scholar
  20. 21.
    Weaver DW, Ledgerwood AM, Lucas CE, Higgins R, Bouwman DL, Johnson SD (1978) Pulmonary effects of albumin resuscitation for severe hypovolemic shock. Arch Surg 113: 387–392PubMedCrossRefGoogle Scholar
  21. 22.
    Guthrie RD Jr, Hines C Jr (1991) Use of intravenous albumin in the critically ill patient. Am J Gastroenterol 86: 255–263PubMedGoogle Scholar
  22. 23.
    Rothschild MA, Oratz M, Schreiber SS (1972) Albumin synthesis. N Engl J Med 286: 748–757PubMedCrossRefGoogle Scholar
  23. 24.
    Chien S, Sinclair DE, Dellenback J, et al (1964) Effect of endotoxin on capillary permeability to macromolecules. Am J Physiol 207: 518–522PubMedGoogle Scholar
  24. 25.
    Margarson MP, Soni N (1998) Serum albumin: touchstone or totem? Anaesthesia 53: 789–803PubMedCrossRefGoogle Scholar
  25. 26.
    Mullen JL, Gertner MH, Buzby GP, Goodhart GL, Rosato EF (1979) Implications of malnutrition in the surgical patient. Arch Surg 114 121–125PubMedCrossRefGoogle Scholar
  26. 27.
    Golub R, Sorrento JJ, Cantu R, Nierman DM, Moideen A, Stein D (1994) Efficacy of albumin supplementation in the surgical intensive care unit: A prospective, randomized study. Crit Care Med 22: 613–619Google Scholar
  27. 28.
    Rubin H, Carlson S, deMeo M, Ganger D, Craig RM (1997) Randomized, double-blind study of intervenous human albumin in hypoalbuminemic patients receiving total parenteral nutrition. Crit Care Med 25: 249–252PubMedCrossRefGoogle Scholar
  28. 29.
    Foley EF, Borlase BC, Dzik WH, Bistrian BR, Benotti PN (1990) Albumin supplementation in the critically ill. Arch Surg 125: 739–742PubMedCrossRefGoogle Scholar
  29. 30.
    Baldo-Enzi G, Baiocchi MR, Vigna G, Andrian C, Mosconi C, Fellin R (1987) Analbuminemia: a natural model of metabolic compensatory systems. J Inherit Metab Dis 10: 317–322PubMedCrossRefGoogle Scholar
  30. 31.
    Weil MH, Henning RJ, Puri VK (1979) Colloid oncotic pressure: clinical significance. Crit Care Med 7: 113–120PubMedCrossRefGoogle Scholar
  31. 32.
    Morissette M, Weil HW, Shubin H (1975) Reduction in colloid osmotic pressure associated with fatal progression of cardiopulmonary failure. Crit Care Med 3: 115–120PubMedCrossRefGoogle Scholar
  32. 33.
    Puri VK, Weil MH, Michaels S, Carlson RW (1980) Pulmonary edema associated with reduction in plasma oncotic pressure. Surg Gynecol Obstet 151: 344–348PubMedGoogle Scholar
  33. 34.
    Alexander MR, Ambre JJ, Liskow BI, Trost DC (1979) Therapeutic use of albumin. JAMA 241: 2527–2729PubMedCrossRefGoogle Scholar
  34. 35.
    Rice CL, Doroghazi PM, Kohler JP, Zarins CK, Moss GS (1979) The effect of sepsis and reduced colloid osmotic pressure on pulmonary edema. J Surg Res 27: 347–351PubMedCrossRefGoogle Scholar
  35. 36.
    Grundmann R, Heistermann S (1985) Postoperative albumin infusion therapy based on colloid osmotic pressure. A prospective randomized trial. Arch Surg 120: 911–915Google Scholar
  36. 37.
    Emerson TE (1989) Unique features of albumin: a brief review. Crit Care Med 17: 690–694PubMedCrossRefGoogle Scholar
  37. 38.
    Jorgensen KA, Stofferson E (1979) Heparin-like activity of albumin. Thromb Res 16: 573–578CrossRefGoogle Scholar
  38. 39.
    Jorgensen KA, Stofferson E (1980) On the inhibitory effects of albumin on platelet aggregation. Thromb Res 17: 13–18PubMedCrossRefGoogle Scholar
  39. 40.
    Tobias MD, Wambold D, Pilla MA, Greer F (1998) Differential effects of serial hemodilution with hydroxyethyl starch, albumin, and 0.9% saline on whole blood coagulation. J Clin Anesth 8: 366–371CrossRefGoogle Scholar
  40. 41.
    Qiao R, Siflinger-Birnboim A, Lum H, Tiruppathi C, Malik AN (1993) Albumin and Ricinus communis agglutinin decrease endothelial permeability via interactions with matrix. Am J Physiol 265: C439 - C446PubMedGoogle Scholar
  41. 42.
    Ring J, Messmer K (1977) Incidence and severity of anaphylactoid reactions to colloid volume substitution. Lancet 1: 467–469Google Scholar
  42. 43.
    Koppel C, Baudiseh H, Ibe K (1988) Inadvertent metal loading of critically ill patients with acute renal failure by human albumin solution infusion therapy. J Toxicol Clin Toxicol 26: 337–357PubMedGoogle Scholar
  43. 44.
    Lee T, Hou X (1994) Comparison of albumin and hespan on myocardial contractility. Anesthesiology 81 (suppl 3A ): A295 (Abst)Google Scholar
  44. 45.
    Choi P, Yip G, Quinonez L, Cook D (1999) Crystalloids versus colloids in fluid resuscitation: A systematic review. Crit Care Med 27: 200–210Google Scholar
  45. 46.
    Members of the American College of Chest Physicians/Society of Critical Care Medicine Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20: 864–874Google Scholar
  46. 47.
    Falk JL, Rackow EC, Astiz M, Weil MH (1988) Effects of hetastarch and albumin on coagulation in patients with septic shock. J Clin Pharmacol 28: 412–415PubMedCrossRefGoogle Scholar
  47. 48.
    Rackow EC, Mecher C, Astiz ME, Griffel M, Falk JL, Weil MH (1989) Effects of pentastarch and albumin infusion on cardiorespiratory function and coagulation in patients with severe sepsis and systemic hypoperfusion. Crit Care Med 17: 394–398PubMedCrossRefGoogle Scholar
  48. 49.
    Stockwell MA, Soni N, Riley B (1992) Colloid solutions in the critically ill. A randomised cornparison of albumin and polygeline. 1. Outcome and duration of stay in the intensive care unit. Anaesthesia 47: 3–6Google Scholar
  49. 50.
    Stockwell MA, Scott A, Day A, Soni N (1992) Colloid solutions in the critically ill. A randomised comparison of albumin and polygeline. 2. Serum albumin concentration and incidences of pulmonary edema and acute renal failure. Anaesthesia 47: 7–9Google Scholar
  50. 51.
    Boldt J, Müller M, Heesen M, Martin K, Hempelmann G (1996) Influence of different volume therapies and pentoxifylline infusion on circulating soluble adhesion molecules in critically ill patients. Crit Care Med 24: 385–391PubMedCrossRefGoogle Scholar
  51. 52.
    Boldt J, Heesen M, Müller M, Pabstdorf M, Hempelmann G (1996) The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Anesth Analg 83: 254–261PubMedGoogle Scholar
  52. 53.
    Boldt J, Müller M, Menges T, Papsdorf M, Hempelmann G (1996) Influence of different volume therapy regimens on regulators of circulation in the critically ill. Br J Anaesth 77: 480–487PubMedCrossRefGoogle Scholar
  53. 54.
    Boldt J, Müller M, Heesen M, Heyn O, Hempelmann G (1996) Influence of different volume therapies on platelet function in the critically ill. Intensive Care Med 22: 1075–1081PubMedCrossRefGoogle Scholar
  54. 55.
    Boldt J, Heesen M, Padberg W, Neumann K, Hempelmann G (1996) Influence of volume therapy and pentoxifylline infusion on circulating adhesion molecules in trauma patients. Anaesthesia 51: 529–535PubMedCrossRefGoogle Scholar
  55. 56.
    Boldt J, Müller M, Mentges D, Papsdorf M, Hempelmann G (1998) Volume therapy in the critically ill: is there a difference? Intensive Care Med 24: 28–36PubMedCrossRefGoogle Scholar
  56. 57.
    Ernest D, Belzberg AS, Dodeck PM (1999) Distribution of normal saline and 5% albumin infusions in septic patients. Crit Care Med 27: 46–50PubMedCrossRefGoogle Scholar
  57. 58.
    Soni N (1995) Wonderful albumin? Br Med J 310: 887–888CrossRefGoogle Scholar
  58. 59.
    Chalmers I (1998) Human albumin administration in critically ill patients - I would not want an albumin transfusion. Br Med J 317: 885Google Scholar
  59. 60.
    Grootendorst AF, van Wilgenburg MG, deLaat PH, van der Hoven B (1988) Albumin abuse in intensive care medicine. Intensive Care Med 14: 554–557PubMedCrossRefGoogle Scholar
  60. 61.
    Hudson LD (1992) Fluid management strategy in acute lung injury. Am Rev Respir Dis 145: 988–989PubMedCrossRefGoogle Scholar
  61. 62.
    Astiz ME, Rackow EC (1999) Crystalloid-colloid controversy revisited. Crit Care Med 27: 34–35PubMedCrossRefGoogle Scholar
  62. 63.
    Jacobs P, Noseworthy W (1990) National estimates of intensive care utilization on costs: Canada and the United States. Crit Care Med 18: 1282–1286Google Scholar
  63. 64.
    Munoz E (1987) Costs of alternative colloid solutions. Infect Surg 12: 643–638Google Scholar
  64. 65.
    Blackburn (1992) Time to abandon routine albumin supplementation. Crit Care Med 20: 157–158PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2000

Authors and Affiliations

  • J. Boldt

There are no affiliations available

Personalised recommendations